115 related articles for article (PubMed ID: 15449141)
1. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.
Fakruddin JM; Laurence J
Arch Virol; 2005 Jan; 150(1):67-78. PubMed ID: 15449141
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
Kino T; Chrousos GP
Ann N Y Acad Sci; 2004 Jun; 1024():153-67. PubMed ID: 15265780
[TBL] [Abstract][Full Text] [Related]
4. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
Ichikawa H; Murakami A; Aggarwal BB
Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
Voronov I; Heersche JN; Casper RF; Tenenbaum HC; Manolson MF
Biochem Pharmacol; 2005 Jul; 70(2):300-7. PubMed ID: 15919055
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
8. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.
Muthumani K; Choo AY; Premkumar A; Hwang DS; Thieu KP; Desai BM; Weiner DB
Cell Death Differ; 2005 Aug; 12 Suppl 1():962-70. PubMed ID: 15832179
[TBL] [Abstract][Full Text] [Related]
10. Dimer formation of receptor activator of nuclear factor kappaB induces incomplete osteoclast formation.
Iwamoto K; Miyamoto T; Sawatani Y; Hosogane N; Hamaguchi I; Takami M; Nomiyama K; Takagi K; Suda T
Biochem Biophys Res Commun; 2004 Dec; 325(1):229-34. PubMed ID: 15522223
[TBL] [Abstract][Full Text] [Related]
11. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
12. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
13. The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1.
Muthumani K; Choo AY; Zong WX; Madesh M; Hwang DS; Premkumar A; Thieu KP; Emmanuel J; Kumar S; Thompson CB; Weiner DB
Nat Cell Biol; 2006 Feb; 8(2):170-9. PubMed ID: 16429131
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.
Muthumani K; Kudchodkar S; Papasavvas E; Montaner LJ; Weiner DB; Ayyavoo V
J Leukoc Biol; 2000 Sep; 68(3):366-72. PubMed ID: 10985253
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.
Janoo A; Morrow PW; Tung HY
J Cell Biochem; 2005 Mar; 94(4):816-25. PubMed ID: 15578586
[TBL] [Abstract][Full Text] [Related]
17. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells.
Kobayashi A; Hirano F; Makino I
Scand J Rheumatol; 2005; 34(6):480-4. PubMed ID: 16393773
[TBL] [Abstract][Full Text] [Related]
19. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1).
Kwak HB; Jin HM; Ha H; Kang MJ; Lee SB; Kim HH; Lee ZH
Biochem Biophys Res Commun; 2005 May; 330(4):1080-6. PubMed ID: 15823554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]